150 related articles for article (PubMed ID: 38798519)
1. Multi-organ structural homogeneity of amyloid fibrils in ATTRv-T60A amyloidosis patients, revealed by Cryo-EM.
Fernandez-Ramirez MDC; Nguyen BA; Singh V; Afrin S; Evers B; Basset P; Wang L; Pękała M; Ahmed Y; Singh P; Canepa J; Wosztyl A; Li Y; Saelices L
bioRxiv; 2024 May; ():. PubMed ID: 38798519
[TBL] [Abstract][Full Text] [Related]
2. Cryo-EM confirms a common fibril fold in the heart of four patients with ATTRwt amyloidosis.
Nguyen BA; Singh V; Afrin S; Singh P; Pekala M; Ahmed Y; Pedretti R; Canepa J; Lemoff A; Kluve-Beckerman B; Wydorski P; Chhapra F; Saelices L
bioRxiv; 2024 Mar; ():. PubMed ID: 38496656
[TBL] [Abstract][Full Text] [Related]
3. Structural polymorphism of amyloid fibrils in ATTR amyloidosis revealed by cryo-electron microscopy.
Nguyen BA; Singh V; Afrin S; Yakubovska A; Wang L; Ahmed Y; Pedretti R; Fernandez-Ramirez MDC; Singh P; Pękała M; Cabrera Hernandez LO; Kumar S; Lemoff A; Gonzalez-Prieto R; Sawaya MR; Eisenberg DS; Benson MD; Saelices L
Nat Commun; 2024 Jan; 15(1):581. PubMed ID: 38233397
[TBL] [Abstract][Full Text] [Related]
4. ATTRv-V30M Type A amyloid fibrils from heart and nerves exhibit structural homogeneity.
Nguyen BA; Afrin S; Yakubovska A; Singh V; Alicea JV; Kunach P; Singh P; Pekala M; Ahmed Y; Fernandez-Ramirez MDC; Hernandez LOC; Pedretti R; Bassett P; Wang L; Lemoff A; Villalon L; Kluve-Beckerman B; Saelices L
bioRxiv; 2024 May; ():. PubMed ID: 38798361
[TBL] [Abstract][Full Text] [Related]
5. Amyloid fibril polymorphism in the heart of an ATTR amyloidosis patient with polyneuropathy attributed to the V122Δ variant.
Ahmed Y; Nguyen BA; Afrin S; Singh V; Evers B; Singh P; Pedretti R; Wang L; Bassett P; Del Carmen Fernandez-Ramirez M; Pekala M; Kluve-Beckerman B; Saelices L
bioRxiv; 2024 May; ():. PubMed ID: 38766262
[TBL] [Abstract][Full Text] [Related]
6. Cryo-EM structure of an ATTRwt amyloid fibril from systemic non-hereditary transthyretin amyloidosis.
Steinebrei M; Gottwald J; Baur J; Röcken C; Hegenbart U; Schönland S; Schmidt M
Nat Commun; 2022 Oct; 13(1):6398. PubMed ID: 36302762
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
Rapezzi C; Elliott P; Damy T; Nativi-Nicolau J; Berk JL; Velazquez EJ; Boman K; Gundapaneni B; Patterson TA; Schwartz JH; Sultan MB; Maurer MS
JACC Heart Fail; 2021 Feb; 9(2):115-123. PubMed ID: 33309574
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen.
Coelho T; Waddington Cruz M; Chao CC; Parman Y; Wixner J; Weiler M; Barroso FA; Dasgupta NR; Jung SW; Schneider E; Viney NJ; Dyck PJB; Ando Y; Gillmore JD; Khella S; Gertz MA; Obici L; Berk JL
Neurol Ther; 2023 Feb; 12(1):267-287. PubMed ID: 36525140
[TBL] [Abstract][Full Text] [Related]
9. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey.
Nativi-Nicolau J; Siu A; Dispenzieri A; Maurer MS; Rapezzi C; Kristen AV; Garcia-Pavia P; LoRusso S; Waddington-Cruz M; Lairez O; Witteles R; Chapman D; Amass L; Grogan M;
JACC CardioOncol; 2021 Oct; 3(4):537-546. PubMed ID: 34729526
[TBL] [Abstract][Full Text] [Related]
10. (99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
Pilebro B; Suhr OB; Näslund U; Westermark P; Lindqvist P; Sundström T
Ups J Med Sci; 2016; 121(1):17-24. PubMed ID: 26849806
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy.
Porcari A; Razvi Y; Masi A; Patel R; Ioannou A; Rauf MU; Hutt DF; Rowczenio D; Gilbertson J; Martinez-Naharro A; Venneri L; Whelan C; Lachmann H; Wechalekar A; Quarta CC; Merlo M; Sinagra G; Hawkins PN; Fontana M; Gillmore JD
Eur J Heart Fail; 2023 Apr; 25(4):515-524. PubMed ID: 36644836
[TBL] [Abstract][Full Text] [Related]
12. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis.
Aus dem Siepen F; Hein S; Hofmann E; Nagel C; Schwarting SK; Hegenbart U; Schönland SO; Weiler M; Frey N; Kristen AV
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673530
[No Abstract] [Full Text] [Related]
14. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
Maestro-Benedicto A; Vela P; de Frutos F; Mora N; Pomares A; Gonzalez-Vioque E; Briceño A; Cabrera E; Cobo-Marcos M; Dominguez F; Gonzalez-Lopez E; Segovia J; Lara-Pezzi E; Garcia-Pavia P
Eur J Heart Fail; 2022 Dec; 24(12):2367-2373. PubMed ID: 35999650
[TBL] [Abstract][Full Text] [Related]
15. Neuromuscular manifestations of wild type transthyretin amyloidosis: a review and single center's experience.
Živković SA; Lacomis D; Soman P
Front Cardiovasc Med; 2024; 11():1345608. PubMed ID: 38410247
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.
Koike H; Katsuno M
Biomedicines; 2019 Feb; 7(1):. PubMed ID: 30764529
[TBL] [Abstract][Full Text] [Related]
17. Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type.
Papagianni A; Ihne S; Zeller D; Morbach C; Üçeyler N; Sommer C
Amyloid; 2022 Mar; 29(1):14-22. PubMed ID: 34632904
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for transthyretin amyloid formation in vitreous body of the eye.
Iakovleva I; Hall M; Oelker M; Sandblad L; Anan I; Sauer-Eriksson AE
Nat Commun; 2021 Dec; 12(1):7141. PubMed ID: 34880242
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin amyloidosis: Putting myopathy on the map.
Pinto MV; Milone M; Mauermann ML; Dyck PJB; Alhammad R; McPhail ED; Grogan M; Liewluck T
Muscle Nerve; 2020 Jan; 61(1):95-100. PubMed ID: 31587306
[TBL] [Abstract][Full Text] [Related]
20. Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.
Koike H; Katsuno M
Neurol Ther; 2020 Dec; 9(2):317-333. PubMed ID: 32948978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
